Numinus Wellness (NUMI) Investor Presentation summary

Market opportunity and industry context

• Global mental health market projected to grow from $380B in 2020 to $538B by 2030, driven by rising rates of mental illness, addiction, and trauma worldwide.

• One in four Canadians and four in ten U.S. adults reported symptoms of depression, anxiety, or PTSD during the pandemic.

• Substance abuse and overdose deaths have surged, with 40.3 million Americans affected and over 106,000 overdose deaths in 2021.

• Current mental health systems are struggling to meet increasing demand.

Business model and operations

• Integrated model combines clinical therapy, psychedelic research, and practitioner training, serving clients, practitioners, and research organizations.

• Transitioned out of Canadian clinical operations, focusing on U.S. clinics and research.

• Wellness clinics generated ~80,000 appointments annually, with 15,750 in Q3 FY24 and a 3.2% year-over-year increase.

• Managed 15 clinical trials at Cedar Clinical Research and facilitated 233 patient appointments in Q3 FY24.

• Practitioner training programs enrolled over 1,650 learners from 18 countries as of May 2024.

Financial performance

• Q3 FY24 total revenue was $4.35M, with clinic network revenues at $3.36M and clinical research revenues at $824K.

• Practitioner training revenues reached $168.8K in Q3 FY24, up 114% from Q2.

• Gross profit margin for Q3 FY24 was 22%, with ongoing cost containment initiatives reducing overhead.

• Cash and cash equivalents stood at $3.7M at quarter end.

• Operating expenses and losses have decreased year-over-year, reflecting efficiency improvements.